Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7) JL Grobe, AP Mecca, M Lingis, V Shenoy, TA Bolton, JM Machado, ... American Journal of Physiology-Heart and Circulatory Physiology 292 (2 …, 2007 | 474 | 2007 |
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension AJ Ferreira, V Shenoy, Y Yamazato, S Sriramula, J Francis, L Yuan, ... American journal of respiratory and critical care medicine 179 (11), 1048-1054, 2009 | 321 | 2009 |
Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents JA Hernández Prada, AJ Ferreira, MJ Katovich, V Shenoy, Y Qi, ... Hypertension 51 (5), 1312-1317, 2008 | 313 | 2008 |
The angiotensin-converting enzyme 2/angiogenesis-(1–7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension V Shenoy, AJ Ferreira, Y Qi, RA Fraga-Silva, C Díez-Freire, A Dooies, ... American journal of respiratory and critical care medicine 182 (8), 1065-1072, 2010 | 310 | 2010 |
Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer Y Yamazato, AJ Ferreira, KH Hong, S Sriramula, J Francis, M Yamazato, ... Hypertension 54 (2), 365-371, 2009 | 196 | 2009 |
Involvement of bone marrow cells and neuroinflammation in hypertension. Monica M. Santisteban, Niousha Ahmari, Jessica Marulanda Carvajal, Michael B ... Circulation Research 117, 78-91., 2015 | 180* | 2015 |
Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models V Shenoy, A Gjymishka, YP Jarajapu, Y Qi, A Afzal, K Rigatto, AJ Ferreira, ... American journal of respiratory and critical care medicine 187 (6), 648-657, 2013 | 175 | 2013 |
Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension V Shenoy, KC Kwon, A Rathinasabapathy, S Lin, G Jin, C Song, P Shil, ... Hypertension 64 (6), 1248-1259, 2014 | 168 | 2014 |
Angiotensin‐converting enzyme 2 activation protects against hypertension‐induced cardiac fibrosis involving extracellular signal‐regulated kinases AJ Ferreira, V Shenoy, Y Qi, RA Fraga‐Silva, RAS Santos, MJ Katovich, ... Experimental physiology 96 (3), 287-294, 2011 | 154 | 2011 |
Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology YF Qi, J Zhang, CT Cole-Jeffrey, V Shenoy, A Espejo, M Hanna, C Song, ... Hypertension 62 (4), 746-752, 2013 | 139 | 2013 |
ACE2, a promising therapeutic target for pulmonary hypertension V Shenoy, Y Qi, MJ Katovich, MK Raizada Current opinion in pharmacology 11 (2), 150-155, 2011 | 126 | 2011 |
Activation of the ACE2/angiotensin-(1–7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors YPR Jarajapu, AD Bhatwadekar, S Caballero, S Hazra, V Shenoy, ... Diabetes 62 (4), 1258-1269, 2013 | 125 | 2013 |
ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy Colleen T Cole-Jeffrey, Meng Liu, Michael J Katovich, Mohan K Raizada ... Journal of Cardiovascular Pharmacology, 2015 | 124 | 2015 |
Angiotensin-converting enzyme 2 activation improves endothelial function RA Fraga-Silva, FP Costa-Fraga, TM Murça, PL Moraes, A Martins Lima, ... Hypertension 61 (6), 1233-1238, 2013 | 118 | 2013 |
Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy J Chen, X Xiao, S Chen, C Zhang, J Chen, D Yi, V Shenoy, MK Raizada, ... Hypertension 61 (3), 681-689, 2013 | 112 | 2013 |
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Erin Bruce1*, Vinayak Shenoy*, Anandharajan Rathinasabapathy, Andrew Espejo ... British Journal of Pharmacology 172, 2219-2231, 2015 | 92 | 2015 |
Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction TM Murça, PL Moraes, CAB Capuruço, SHS Santos, MB Melo, ... Regulatory peptides 177 (1-3), 107-115, 2012 | 83 | 2012 |
Lentivirus‐mediated overexpression of angiotensin‐(1–7) attenuated ischaemia‐induced cardiac pathophysiology YF Qi, V Shenoy, F Wong, H Li, A Afzal, J Mocco, C Sumners, MK Raizada, ... Experimental physiology 96 (9), 863-874, 2011 | 82 | 2011 |
Moderate cardiac‐selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury Y Qi, H Li, V Shenoy, Q Li, F Wong, L Zhang, MK Raizada, C Sumners, ... Experimental physiology 97 (1), 89-101, 2012 | 67 | 2012 |
17β-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats V Shenoy, JL Grobe, Y Qi, AJ Ferreira, RA Fraga-Silva, G Collamat, ... Peptides 30 (12), 2309-2315, 2009 | 60 | 2009 |